Multiomics of three hematological malignancies in a patient reveal their origin from clonal hematopoietic stem cells-Reference-Cited by-同舟云学术

Multiomics of three hematological malignancies in a patient reveal their origin from clonal hematopoietic stem cells

Published:2023-08-09 Issue:1 Volume:13 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Mayeur Sylvain,Molitor Anne,Miguet Laurent,Rigolot Lucie,Naegely Lydie,Stemmelen Tristan,Meyer Sébastien^ORCID,Toussaint Elise,Vallat Laurent,Eischen Alice,Chenard Marie-Pierre,Tavian Manuela,Bahram Seiamak^ORCID,Carapito Raphael^ORCID,Nicolae Alina^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

https://www.nature.com/articles/s41408-023-00892-w.pdf

Reference16 articles.

1. Kuppers R, Duhrsen U, Hansmann ML. Pathogenesis, diagnosis, and treatment of composite lymphomas. Lancet Oncol. 2014;15:e435–46.

2. Lewis NE, Petrova-Drus K, Huet S, Epstein-Peterson ZD, Gao Q, Sigler AE, et al. Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms. Blood Adv. 2020;4:2261–71.

3. Martinez A, Pittaluga S, Villamor N, Colomer D, Rozman M, Raffeld M, et al. Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis. Am J Surg Pathol. 2004;28:849–58.

4. Yoshihara K, Nannya Y, Matsuda I, Samori M, Utsunomiya N, Okada M, et al. T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone. EJHaem. 2022;3:211–4.

5. Huang L, Meng C, Liu D, Fu XJ. Secondary peripheral T-cell lymphoma and acute myeloid leukemia after Burkitt lymphoma treatment: A case report. World J Clin Cases. 2021;9:7237–44.